市場調査レポート

商品コード

1633663

咬合デバイス市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 2025～2032年産業予測

Occlusion Devices Market Size, Share, Growth Analysis, By Product (Occlusion Removal Devices, Embolization Devices), By Application (Neurology, Cardiology), By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年01月12日
発行: SkyQuest
ページ情報: 英文 232 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 3,500 513,870円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 4,400 646,008円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 5,300 778,146円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
目次

概要

サンプル依頼リストに入れる

咬合デバイスの世界市場規模は2023年に29億4,000万米ドルとなり、予測期間（2025～2032年）のCAGRは5.1%で、2024年の30億9,000万米ドルから2032年には46億米ドルに成長する見通しです。

世界の咬合デバイス市場は、心血管疾患、神経血管障害、末梢血管疾患の罹患率上昇に牽引され、堅調な成長軌道にあります。閉塞除去装置、塞栓装置、サポート装置などの主要製品は、効果的な治療プロトコルに不可欠です。高齢化と低侵襲手術技術の進歩が市場拡大をさらに後押ししています。さらに、血管内治療へのシフトや外来手術センターのような外来患者への嗜好の高まりが需要を押し上げています。北米は心血管疾患の有病率が高く、大手メーカーが存在するため、市場をリードしています。一方、欧州とアジア太平洋は、ヘルスケアインフラの充実と患者の意識の高まりにより、大きな成長を遂げています。この動向は近い将来も続くと予想されます。

市場概要
閉塞除去装置
- バルーン咬合デバイス
- ステント回収デバイス
- コイルレトリーバー
- 吸引・吸引デバイス
塞栓デバイス
- 塞栓コイル
- 液体塞栓剤
- チューブル咬合デバイス
サポートデバイス
- マイクロカテーテル
- ガイドワイヤー

咬合デバイス市場規模：用途別とCAGR（2025～2032年）

市場概要
神経学
心臓病学
末梢血管疾患
泌尿器科
腫瘍学
婦人科

咬合デバイス市場規模：エンドユーザー別とCAGR（2025～2032年）

市場概要
病院
診断センター
外科センター
外来診療センター
調査室および学術機関

咬合デバイス市場規模とCAGR（2025～2032年）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022～2024年）

主要企業プロファイル

Boston Scientific Corporation（United States）
Medtronic PLC（Ireland）
Terumo Corporation（Japan）
Stryker Corporation（United States）
Penumbra, Inc.（United States）
Abbott Laboratories（United States）
Edwards Lifesciences Corporation（United States）
Johnson & Johnson（United States）
Merit Medical Systems, Inc.（United States）
Lepu Medical Technology Co., Ltd.（China）
Asahi Intecc Co., Ltd.（Japan）
AngioDynamics, Inc.（United States）
Cardinal Health, Inc.（United States）
Avinger, Inc.（United States）
B. Braun Melsungen AG（Germany）
C.R. Bard, Inc.（United States）
Cook Medical Incorporated（United States）
Acrostak International Distribution Sarl（Switzerland）

結論と推奨事項

Product Code: SQMIG35A2550

Global Occlusion Devices Market size was valued at USD 2.94 billion in 2023 and is poised to grow from USD 3.09 billion in 2024 to USD 4.6 billion by 2032, growing at a CAGR of 5.1% during the forecast period (2025-2032).

The global occlusion devices market is on a robust growth trajectory, driven by the rising incidence of cardiovascular diseases, neurovascular disorders, and peripheral vascular conditions. Key products including occlusion removal devices, embolization devices, and support devices are integral to effective treatment protocols. The aging population and advancements in minimally invasive surgical techniques are further propelling market expansion. Moreover, the shift towards endovascular procedures and an increasing preference for outpatient settings, like ambulatory surgical centers, are boosting demand. North America leads the market, thanks to a high prevalence of cardiovascular issues and the presence of major manufacturers. Meanwhile, Europe and Asia-Pacific are experiencing significant growth due to enhanced healthcare infrastructure and rising patient awareness. This trend is expected to persist in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Occlusion Devices Market Segmental Analysis

Global Occlusion Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Occlusion Removal Devices, Embolization Devices and Support Devices. Based on Application, the market is segmented into Neurology, Cardiology, Peripheral Vascular Diseases, Urology,oncologyand Gynecology. Based on End User, the market is segmented into Hospitals, Diagnostic Centers,, Surgical Centers, Ambulatory Care Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Occlusion Devices Market

The global occlusion devices market is primarily driven by the rising prevalence of cardiovascular and neurovascular diseases, as well as peripheral vascular conditions. The growing incidence of these health issues necessitates effective therapeutic solutions like occlusion devices to restore blood flow and mitigate complications. This demand is further amplified by an aging population and increasing unhealthy lifestyle choices. Additionally, advancements in minimally invasive techniques have transformed occlusion treatment, offering patients non-surgical options that reduce trauma, expedite recovery, and enhance outcomes. The introduction of innovative devices, including occlusion removal and embolization devices, with improved safety and efficacy, is fostering significant market growth.

Restraints in the Global Occlusion Devices Market

The global occlusion devices market faces several significant restraints, primarily due to rigorous regulatory approval processes designed to ensure patient safety and product effectiveness. Securing necessary approvals, such as those from the FDA or obtaining CE marking, is often a lengthy and expensive endeavor. This regulatory landscape presents considerable hurdles, especially for small and medium-sized enterprises looking to enter or enhance their market footprint. Additionally, the high costs associated with manufacturing occlusion devices-encompassing occlusion removal, embolization, and support devices-are another limiting factor. The substantial expenses tied to research, development, and the use of specialized materials drive up prices, restricting market access and adoption, particularly in regions with constrained healthcare budgets and emerging economies where affordability is a critical concern.

Market Trends of the Global Occlusion Devices Market

The Global Occlusion Devices market is witnessing a significant shift towards bioresorbable occlusion devices, driven by their ability to dissolve and be absorbed by the body, thereby eliminating the need for device removal procedures. This burgeoning demand is largely fueled by the advantages these devices offer, including minimized long-term complications and enhanced patient comfort. Manufacturers are increasingly channeling investments into research and development to refine bioresorbable materials, focusing on boosting safety and efficacy. This trend reflects a broader movement toward patient-centric healthcare solutions, highlighting a growing preference for personalized treatment options within the realm of occlusion device interventions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Occlusion Devices Market Size by Product & CAGR (2025-2032)

Market Overview
Occlusion Removal Devices
- Balloon Occlusion Devices
- Stent Retrievers
- Coil Retrievers
- Suction & Aspiration Devices
Embolization Devices
- Embolic Coils
- Liquid Embolic Agents
- Tubal Occlusion Devices
Support Devices
- Microcatheters
- Guidewires

Global Occlusion Devices Market Size by Application & CAGR (2025-2032)

Market Overview
Neurology
Cardiology
Peripheral Vascular Diseases
Urology
Oncology
Gynecology

Global Occlusion Devices Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals
Diagnostic Centers,
Surgical Centers
Ambulatory Care Centers
Research Laboratories & Academic Institutes

Global Occlusion Devices Market Size & CAGR (2025-2032)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avinger, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C.R. Bard, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acrostak International Distribution Sarl (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments